European Journal of Medicinal Chemistry p. 133 - 139 (1995)
Update date:2022-08-03
Topics:
Colotta, V.
Cecchi, L.
Catarzi, D.
Filacchioni, G.
Martini, C.
et al.
The syntheses, A%1 and A2a adenosine receptor affinities and structure-activity relationships of some 2-aryl-1,2,4-triazolo<1,5-a>quinoxalines, 2-arylimidazo<1,2-a>quinoxalines, 1-arylimidazo<1,5-a>quinoxalines are reported and compared with that of a previously reported 2-phenylpyrazolo<1,5-a>quinoxaline.The results show that some triazoloquinoxalines are potent and specific A1 adenosine receptor ligands and that the replacement of either nitrogen at position 1 or 3 of the triazoloquinoxaline moiety with a CH brought about a decrease in affinity at both adenosine receptors. adenosine receptor ligand / 1,2,4-triazolo<1,5-a>quinoxaline / imidazo<1,2-a>quinoxaline / imidazo<1,5-a>quinoxaline / tricyclic heteroaromatic system
View MoreZhejiang Allied Chemical Co.,Ltd
Contact:18967038207
Address:Area A-30, High-tech Industrial Park, Quzhou, Zhejiang, China.
Contact:+86-571-87010026
Address:202, Zhenhua Road,
Weihao Chemtech (ChangZhou) Co., Ltd.(expird)
Contact:051989185693
Address:NO 217 huangshan Rd ,Changzhou
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Changzhou Extraordinary Pharmatech co.,LTD
website:http://www.feifanchem.com
Contact:+86 519 82111935
Address:Chinese Jiangsu Province Changzhou City Jintan District Jincheng Town Miaotou NO4(Pharmaceutical Park)
Doi:10.1002/jhet.5570320334
(1995)Doi:10.1002/adsc.201300698
(2013)Doi:10.1039/DT9950002469
(1995)Doi:10.1021/ja01191a051
(1948)Doi:10.1139/v63-323
(1963)Doi:10.1021/jo01148a001
(1950)